产品基本信息

货号：1446

产品名称：trFluor™Eu DBCO

规格：100ug

储存条件：-15℃避光防潮

保质期：24个月

产品物理化学光谱特性

分子量：1765.72

外观：固体

溶剂：DMSO

激发波长(nm)：346

发射波长(nm)：617

产品介绍

存在于细胞，血清或其他生物流体中的许多生物化合物都是天然荧光的，因此，由于要测定的生物分子的自发荧光引起的高背景，使用常规的快速荧光团会严重限制测定灵敏度。长寿命荧光团与时间分辨检测（激发和发射检测之间的延迟）的结合使用可最大程度地减少即时荧光干扰。我们的trFluor™Eu探针可用于需要高灵敏度测定的时间分辨荧光（TRF）。与诸如Alexa Fluor或花青染料等更传统的荧光团相比，这些trFluor™Eu探针具有较大的斯托克斯位移和极长的发射半衰期。与其他TRF化合物相比，我们的trFluor™Eu探针具有相对较高的稳定性，高发射率和与生物分子连接的能力。此外，当与生物聚合物（例如抗体）偶联时，我们的trFluor™Eu探针对荧光猝灭不敏感。在无铜条件下，trFluor™Eu DBCO可以容易地单击成含有叠氮基的分子。金畔生物是AAT Bioquest的中国代理商，为您提供最优质的trFluor™I DBCO。 

点击查看光谱

参考文献

Comparative Analysis of High-Throughput Assays of Family-1 Plant Glycosyltransferases.
Authors: McGraphery, Kate and Schwab, Wilfried
Journal: International journal of molecular sciences (2020)

Discovery and Characterization of Peptide Inhibitors for Calcium and Integrin Binding Protein 1.
Authors: Puhl, Ana C and Bogart, Jonathan W and Haberman, Victoria A and Larson, Jacob E and Godoy, Andre S and Norris-Drouin, Jacqueline L and Cholensky, Stephanie H and Leisner, Tina M and Frye, Stephen V and Parise, Leslie V and Bowers, Albert A and Pearce, Kenneth H
Journal: ACS chemical biology (2020)

Integrating Ligand and Target-Driven Based Virtual Screening Approaches With in vitro Human Cell Line Models and Time-Resolved Fluorescence Resonance Energy Transfer Assay to Identify Novel Hit Compounds Against BCL-2.
Authors: Tutumlu, Gurbet and Dogan, Berna and Avsar, Timucin and Orhan, Muge Didem and Calis, Seyma and Durdagi, Serdar
Journal: Frontiers in chemistry (2020): 167

Revisit ligand-receptor interaction at the human vasopressin V2 receptor: A kinetic perspective.
Authors: Liu, Chunji and Xia, Leyi and Fu, Kequan and Cao, Xudong and Yan, Wenzhong and Cheng, Jianjun and Roux, Thomas and Peletier, Lambertus A and Yin, Xiaoxing and Guo, Dong
Journal: European journal of pharmacology (2020): 173157

A General TR-FRET Assay Platform for High-Throughput Screening and Characterizing Inhibitors of Methyl-Lysine Reader Proteins.
Authors: Rectenwald, Justin M and Hardy, P Brian and Norris-Drouin, Jacqueline L and Cholensky, Stephanie H and James, Lindsey I and Frye, Stephen V and Pearce, Kenneth H
Journal: SLAS discovery : advancing life sciences R & D (2019): 693-700

A high-throughput screen of pharmacologically active compounds for inhibitors of UHRF1 reveals epigenetic activity of anthracycline derivative chemotherapeutic drugs.
Authors: Giovinazzo, Hugh and Walker, David and Wyhs, Nicolas and Liu, Jianyong and Esopi, David M and Vaghasia, Ajay M and Jain, Yash and Bhamidipati, Akshay and Zhou, Jianya and Nelson, William G and Yegnasubramanian, Srinivasan
Journal: Oncotarget (2019): 3040-3050

Development of a High-Throughput Cul3-Keap1 Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay for Identifying Nrf2 Activators.
Authors: Poore, Derek D and Hofmann, Glenn and Wolfe, Lawrence A and Qi, Hongwei and Jiang, Ming and Fischer, Michael and Wu, Zining and Sweitzer, Thomas D and Chakravorty, Subhas and Donovan, Brian and Li, Hu
Journal: SLAS discovery : advancing life sciences R & D (2019): 175-189

LFRET, a novel rapid assay for anti-tissue transglutaminase antibody detection.
Authors: Rusanen, Juuso and Toivonen, Anne and Hepojoki, Jussi and Hepojoki, Satu and Arikoski, Pekka and Heikkinen, Markku and Vaarala, Outi and Ilonen, Jorma and Hedman, Klaus
Journal: PloS one (2019): e0225851

Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
Authors: Miller, Thomas W and Amason, Joshua D and Garcin, Elsa D and Lamy, Laurence and Dranchak, Patricia K and Macarthur, Ryan and Braisted, John and Rubin, Jeffrey S and Burgess, Teresa L and Farrell, Catherine L and Roberts, David D and Inglese, James
Journal: PloS one (2019): e0218897

Development of a Broadly Applicable Assay for Measurement of Glycan-Directed Enzymatic Activity.
Authors: Bresciani, Alberto and Cecchetti, Ottavia and Missineo, Antonino and Pacifici, Pier Giorgio and Tomei, Licia and Rodems, Steven
Journal: SLAS discovery : advancing life sciences R & D (2018): 941-950